Changchun BCHT Biotechnology Co. (SHA:688276)
China
· Delayed Price · Currency is CNY 19.00
+0.25 (1.33%)
Mar 10, 2026, 3:00 PM CST
SHA:688276 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | - | 344.87 | 442.18 | 866.54 | 1,156 | Upgrade
|
| Cash & Short-Term Investments | 157.44 | 344.87 | 442.18 | 866.54 | 1,156 | Upgrade
|
| Cash Growth | -54.35% | -22.01% | -48.97% | -25.01% | 273.22% | Upgrade
|
| Accounts Receivable | - | 1,407 | 1,567 | 968.41 | 763.94 | Upgrade
|
| Receivables | - | 1,407 | 1,567 | 968.41 | 763.94 | Upgrade
|
| Inventory | - | 170.78 | 199.02 | 192.11 | 241.34 | Upgrade
|
| Prepaid Expenses | - | 1.11 | 0.92 | 0.1 | - | Upgrade
|
| Other Current Assets | - | 41.21 | 35.26 | 30.81 | 29.15 | Upgrade
|
| Total Current Assets | - | 1,965 | 2,245 | 2,058 | 2,190 | Upgrade
|
| Property, Plant & Equipment | - | 2,478 | 2,085 | 1,642 | 1,439 | Upgrade
|
| Long-Term Investments | - | 211.34 | 207.57 | 61.28 | 69.12 | Upgrade
|
| Other Intangible Assets | - | 330.6 | 347.45 | 204.02 | 223.72 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 96.28 | 90.97 | 54.2 | 31.93 | Upgrade
|
| Long-Term Deferred Charges | - | 74.68 | 29.26 | 211.09 | 159.25 | Upgrade
|
| Other Long-Term Assets | - | 49.56 | 41.06 | 53.06 | 61.95 | Upgrade
|
| Total Assets | - | 5,205 | 5,046 | 4,284 | 4,175 | Upgrade
|
| Accounts Payable | - | 13.81 | 17.49 | 24.8 | 63.91 | Upgrade
|
| Accrued Expenses | - | 533.19 | 553.18 | 340.9 | 422.69 | Upgrade
|
| Short-Term Debt | - | 42.9 | 20.47 | - | - | Upgrade
|
| Current Income Taxes Payable | - | - | 48.89 | 5.07 | - | Upgrade
|
| Current Unearned Revenue | - | 2.2 | 0.28 | 8.65 | 10.21 | Upgrade
|
| Other Current Liabilities | - | 324.97 | 374.56 | 337.27 | 251.89 | Upgrade
|
| Total Current Liabilities | - | 917.07 | 1,015 | 716.68 | 748.71 | Upgrade
|
| Long-Term Debt | - | 59.93 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | 9 | 9.86 | 5.92 | 8.09 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.88 | 0.98 | 1.11 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.24 | 0.17 | 0.31 | 0.25 | Upgrade
|
| Total Liabilities | - | 987.12 | 1,026 | 724.02 | 757.05 | Upgrade
|
| Common Stock | - | 413.66 | 412.84 | 412.84 | 412.84 | Upgrade
|
| Additional Paid-In Capital | - | 1,840 | 1,820 | 1,778 | 1,771 | Upgrade
|
| Retained Earnings | - | 1,989 | 1,819 | 1,380 | 1,240 | Upgrade
|
| Comprehensive Income & Other | - | -25.27 | -31.86 | -10.96 | -5.75 | Upgrade
|
| Shareholders' Equity | 3,958 | 4,218 | 4,020 | 3,560 | 3,418 | Upgrade
|
| Total Liabilities & Equity | - | 5,205 | 5,046 | 4,284 | 4,175 | Upgrade
|
| Total Debt | 274.6 | 102.83 | 20.47 | - | - | Upgrade
|
| Net Cash (Debt) | -117.16 | 242.04 | 421.71 | 866.54 | 1,156 | Upgrade
|
| Net Cash Growth | - | -42.60% | -51.33% | -25.01% | 273.22% | Upgrade
|
| Net Cash Per Share | -0.28 | 0.58 | 1.02 | 2.10 | 2.94 | Upgrade
|
| Filing Date Shares Outstanding | 399.56 | 413.66 | 412.84 | 412.84 | 412.84 | Upgrade
|
| Total Common Shares Outstanding | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 | Upgrade
|
| Working Capital | - | 1,048 | 1,230 | 1,341 | 1,441 | Upgrade
|
| Book Value Per Share | 9.57 | 10.20 | 9.74 | 8.62 | 8.28 | Upgrade
|
| Tangible Book Value | 3,629 | 3,887 | 3,673 | 3,356 | 3,194 | Upgrade
|
| Tangible Book Value Per Share | 8.77 | 9.40 | 8.90 | 8.13 | 7.74 | Upgrade
|
| Buildings | - | 547.95 | 487.92 | 374.62 | 307.51 | Upgrade
|
| Machinery | - | 945.72 | 826.34 | 509.79 | 451.85 | Upgrade
|
| Construction In Progress | - | 1,386 | 1,101 | 1,038 | 919.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.